Bolt Biotherapeutics (BOLT) Current Leases (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Current Leases of $3.0 million for Q1 2026, up 4.6% sequentially from $2.8 million in Q4 2025, and up 23.17% YoY from $2.4 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Current Leases (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Current Leases for 7 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Current Leases rose 23.17% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 23.17% YoY) and the FY2025 annual result came in at $2.8 million, up 25.54% from the prior year.
- Current Leases climbed to $3.0 million in Q1 2026 per BOLT's latest filing, from $2.8 million in the prior quarter.
- Over five years, Current Leases peaked at $3.0 million in Q2 2024 and troughed at $2.1 million in Q1 2022.
- A 5-year average of $2.6 million and a median of $2.6 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2024: Current Leases grew 26.6% in 2022, then slipped 19.09% in 2024.
- Over 5 years, Current Leases stood at $2.4 million in 2022, then rose by 16.35% to $2.8 million in 2023, then slipped by 19.09% to $2.3 million in 2024, then grew by 25.54% to $2.8 million in 2025, then increased by 4.6% to $3.0 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $3.0 million, $2.8 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | 3.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.09 Mn |
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.56 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 2.89 Mn |
| Dec 31, 2023 | 2.78 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | 2.58 Mn |
| Mar 31, 2023 | 2.48 Mn |
| Dec 31, 2022 | 2.39 Mn |
| Sep 30, 2022 | 2.38 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 2.06 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 2.41 Mn |